Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

Chakaya, J, Khan, Mishal, Ntoumi, Francine, Aklillu, Eleni, Fatima, Razia, Mwaba, Peter, Kapata, Nathan, Mfinanga, Sayoki, Hasnain, Seyed Ehtesham, Katoto, Patrick D.M.C., Bulabula, André N.H., Sam-Agudu, Nadia A., Nachega, Jean B., Tiberi, Simon, McHugh, Timothy D., Abubakar, Ibrahim and Zumla, Alimuddin (2021) 'Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts'. International Journal of Infectious Diseases, Vol 113, Issue S1, S7-S12.

Text PIIS1201971221001934.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (306kB)

Abstract

The October 2020 Global TB report reviews TB control strategies and United Nations (UN) targets set in the political declaration at the September 2018 UN General Assembly high-level meeting on TB held in New York. Progress in TB care and prevention has been very slow. In 2019, TB remained the most common cause of death from a single infectious pathogen. Globally, an estimated 10.0 million people developed TB disease in 2019, and there were an estimated 1.2 million TB deaths among HIV-negative people and an additional 208, 000 deaths among people living with HIV. Adults accounted for 88% and children for 12% of people with TB. The WHO regions of South-East Asia (44%), Africa (25%), and the Western Pacific (18%) had the most people with TB. Eight countries accounted for two thirds of the global total: India (26%), Indonesia (8.5%), China (8.4%), the Philippines (6.0%), Pakistan (5.7%), Nigeria (4.4%), Bangladesh (3.6%) and South Africa (3.6%). Only 30% of the 3.5 million five-year target for children treated for TB was met. Major advances have been development of new all oral regimens for MDRTB and new regimens for preventive therapy. In 2020, the COVID-19 pandemic dislodged TB from the top infectious disease cause of mortality globally. Notably, global TB control efforts were not on track even before the advent of the COVID-19 pandemic. Many challenges remain to improve sub-optimal TB treatment and prevention services. Tuberculosis screening and diagnostic test services need to be ramped up. The major drivers of TB remain undernutrition, poverty, diabetes, tobacco smoking, and household air pollution and these need be addressed to achieve the WHO 2035 TB care and prevention targets. National programs need to include interventions for post-tuberculosis holistic wellbeing. From first detection of COVID-19 global coordination and political will with huge financial investments have led to the development of effective vaccines against SARS-CoV2 infection. The world now needs to similarly focus on development of new vaccines for TB utilizing new technological methods.

Item Type:	Article
Subjects:	WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries WF Respiratory System > WF 140 Diseases of the respiratory system (General) WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 310 Therapy
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1016/j.ijid.2021.02.107
Depositing User:	Stacy Murtagh
Date Deposited:	07 Apr 2021 14:06
Last Modified:	28 Jul 2022 15:54
URI:	https://archive.lstmed.ac.uk/id/eprint/17466

Statistics

View details

Actions (login required)

Edit Item